Is MIRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.

MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis - Financials

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of August 15, 2026, MIRA trades at $0.79 with a market cap of $32.79M and a P/E ratio of -0.58. MIRA moved +0.00% today. Year to date, MIRA is -48.33%; over the trailing twelve months it is -46.93%. Its 52-week range spans $0.60 to $2.45. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MIRA's key financials?

MIRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MIRA recently traded at $0.79. Market cap is $32.79M. P/E ratio is -0.58. Revenue is $0.

MIRA Key Metrics

Key financial metrics for MIRA
Metric	Value
Price	$0.79
Market Cap	$32.79M
P/E Ratio	-0.58
EPS	$-1.35
Dividend Yield	0.00%
52-Week High	$2.45
52-Week Low	$0.60
Volume	67.02K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.44M
Gross Margin	0.00%

MIRA Analyst Consensus

MIRA analyst coverage data. Average price target: $0.00.

Common questions about MIRA

What are MIRA's key financials?: MIRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MIRA recently traded at $0.79. Market cap is $32.79M. P/E ratio is -0.58. Revenue is $0.
Is MIRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.